Literature DB >> 19012958

Failure of the Merck HIV vaccine: an uncertain step forward.

Merlin L Robb1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19012958     DOI： 10.1016/S0140-6736(08)61593-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

Review 1.  The use of cell-delivered gene therapy for the treatment of HIV/AIDS.

Authors:  Geoff P Symonds; Helen A Johnstone; Michelle L Millington; Maureen P Boyd; Bryan P Burke; Louis R Breton
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine.

Authors:  Géraldine Arrode-Brusés; Darlene Sheffer; Ramakrishna Hegde; Sukbir Dhillon; Zhengian Liu; François Villinger; Opendra Narayan; Yahia Chebloune
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

3.  The STEP study provides a hint that vaccine induction of the right CD8+ T cell responses can facilitate immune control of HIV.

Authors:  Marcus Altfeld; Philip J Goulder
Journal:  J Infect Dis       Date:  2011-03-15       Impact factor: 5.226

Review 4.  Vaccine Design Informed by Virus-Induced Immunity.

Authors:  Rhiannon R Penkert; Jane S Hankins; Neal S Young; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-05-05       Impact factor: 2.257

5.  Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.

Authors:  Zaza M Ndhlovu; Alicja Piechocka-Trocha; Seanna Vine; Ashley McMullen; Kegakilwe C Koofhethile; Phillip J R Goulder; Thumbi Ndung'u; Dan H Barouch; Bruce D Walker
Journal:  J Immunol       Date:  2011-05-16       Impact factor: 5.422

Review 6.  Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

Authors:  Jessica L Smith; Wei Bu; Ryan C Burdick; Vinay K Pathak
Journal:  Trends Pharmacol Sci       Date:  2009-12       Impact factor: 14.819

7.  Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men.

Authors:  Marcel E Curlin; Meei-Li Huang; Xiaoyan Lu; Connie L Celum; Jorge Sanchez; Stacy Selke; Jared M Baeten; Richard A Zuckerman; Dean D Erdman; Lawrence Corey
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

8.  Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Authors:  Scott A Brown; Sherri L Surman; Robert Sealy; Bart G Jones; Karen S Slobod; Kristen Branum; Timothy D Lockey; Nanna Howlett; Pamela Freiden; Patricia Flynn; Julia L Hurwitz
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.048

9.  SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

Authors:  Robert Sealy; Xiaoyan Zhan; Timothy D Lockey; Louis Martin; James Blanchard; Vicki Traina-Dorge; Julia L Hurwitz
Journal:  Curr HIV Res       Date:  2009-09       Impact factor: 1.581

Review 10.  HIV prevention cost-effectiveness: a systematic review.

Authors:  Omar Galárraga; M Arantxa Colchero; Richard G Wamai; Stefano M Bertozzi
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.